Clinical Trial Update: Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 trial evaluating the combination of paclitaxel, carboplatin, and gemcitabine in patients with advanced transition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED